Is Follistatin 344 FDA-approved?

No. Follistatin 344 isn't FDA-approved, and Drugs@FDA lists no application with follistatin as an active ingredient.

Checked 1 Nov 2026. The sources are below.

Follistatin 344

Also: FST344, FS344, follistatin, activin-binding protein

Status label in the Peptimes Library
Not FDA-Approved
Routes in Peptimes
Intramuscular
Updated
1 Nov 2026

US regulatory status

  • FDA status

    Not FDA-Approved. Drugs@FDA lists no application with follistatin as an active ingredient.

    Source: Drugs@FDA, checked 1 Nov 2026

How to track it in Peptimes

Add follistatin 344 in My Protocols and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose. Its Library entry shows the status label “Not FDA-Approved”.

  • Logging: the amount you took and how you feel.
  • Injection sites: each dose records the site, and Insights shows where you’ve injected and how recently. It never suggests where to inject next.
  • Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.

Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell follistatin 344 or any other compound.

More sources

  • FDA, Global Substance Registration System, Follistatin, checked 1 Nov 2026: a protein, with the names activin-binding protein and FST.
  • ClinicalTrials.gov, searched 1 Nov 2026: the registered studies are of follistatin gene therapies, which are different products, not of follistatin protein.

Coming soon to the App Store

Coming soon to Google Play

See planned pricing